European Case Law Identifier: | ECLI:EP:BA:2001:T047997.20010906 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 06 September 2001 | ||||||||
Case number: | T 0479/97 | ||||||||
Application number: | 89810545.7 | ||||||||
IPC class: | C12N 15/60 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Novel expression system | ||||||||
Applicant name: | Novartis AG | ||||||||
Opponent name: | DSM Gist Holding B.V. | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Right to priority - main request - part of claim 1 and claim 5 - (no) - auxiliary request - (yes) Novelty - main and auxiliary requests - (yes) Inventive step - main request (no) - auxiliary request (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t970479eu1.html
Date retrieved: 17 May 2021
7 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: II Conditions to be met by an Application
XCLR II D 3.1.5 Explicit or implicit disclosure of the features of the invention in the priority document
XCLR II D 3.1.5.B Example cases – features of the invention not all disclosed in the priority document